Cryoablation Combined with Molecular Target Therapy Improves the Curative Effect in Patients with Advanced Non-Small Cell Lung Cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of International Medical Research

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/147323001103900516PMID 22117974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

  2011cited by this paper
• Percutaneous cryoablation of small hepatocellular carcinomas using a 17-gauge ultrathin probe.

  2011cited by this paper
• How I Do It: Radiofrequency Ablation and Cryoablation of Lung Tumors

  2011cited by this paper
• First- or second-line gefitinib therapy in unknown epidermal growth factor receptor mutants of non-small-cell lung cancer patients treated in Taiwan.

  2011cited by this paper
• Comprehensive Analysis of Epidermal Growth Factor Receptor Gene Status in Lung Adenocarcinoma

  2011cited by this paper
• American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.

  2011cited by this paper
• A front‐line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer

  2010cited by this paper
• 中国肺癌发病死亡的估计和流行趋势研究

  2010cited by this paper
• Morphology of hypoxia following cryoablation in a prostate cancer murine model: its relationship to necrosis, apoptosis and, microvessel density.

  2010cited by this paper
• Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma.

  2009cited by this paper
• Comparison of FISH, PCR, and Immunohistochemistry in Assessing EGFR Status in Lung Adenocarcinoma and Correlation With Clinicopathologic Features

  2009cited by this paper
• Percutaneous computed tomography-guided radiofrequency ablation of lung tumors complicated with idiopathic interstitial pneumonia.

  2009cited by this paper
• [Clinical analysis of resected pulmonary pleomorphic carcinoma].

  2009cited by this paper
• Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer.

  2009cited by this paper
• Angiogenic Markers Show High Prognostic Impact on Survival in Marginally Operable Non-small Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy

  2009cited by this paper
• Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.

  2009cited by this paper
• A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer

  2009cited by this paper
• [New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis].

  2008cited by this paper
• Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.

  2008cited by this paper
• Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer

  2008cited by this paper
• Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

  2008cited by this paper
• Complications of ablative therapies in lung cancer.

  2008cited by this paper
• Evidence for Disease Control with Erlotinib after Gefitinib Failure in Typical Gefitinib-Sensitive Asian Patients with Non-small Cell Lung Cancer

  2008cited by this paper
• First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.

  2008cited by this paper
• Hypoxia, angiogenesis, and lung cancer

  2008cited by this paper
• Nieuwe middelen voor de behandeling van gemetastaseerd niet-kleincellig longcarcinoom: remmers van de epidermale groeifactorreceptor en van de angiogenese

  2008cited by this paper
• Epidermal growth factor receptor mutations in lung cancer

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Lung Isolation, One-Lung Ventilation, and Continuous Positive Airway Pressure with Air for Radiofrequency Ablation of Neoplastic Pulmonary Lesions

  2006cited by this paper
• First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.

  2006cited by this paper
• A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

  2006cited by this paper
• Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer

  2006cited by this paper
• Gefitinib is of more benefit in chemotherapy-naive patients with good performance status and adenocarcinoma histology: retrospective analysis of 575 Korean patients.

  2006cited by this paper
• Gefitinib as front-line treatment in Chinese patients with advanced non-small-cell lung cancer.

  2006cited by this paper
• Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese.

  2006cited by this paper
• Gefitinib-Sensitive Mutations of the Epidermal Growth Factor Receptor Tyrosine Kinase Domain in Chinese Patients with Non–Small Cell Lung Cancer

  2005cited by this paper
• Cryosurgery for malignant endobronchial tumors: analysis of outcome.

  2005cited by this paper
• The application of cryosurgery in the treatment of lung cancer.

  2004cited by this paper
• Gefitinib (Iressa) trials in non-small cell lung cancer.

  2003cited by this paper
• Gefitinib (ZD1839, Iressa®): a selective epidermal growth factor receptor-tyrosine kinase inhibitor

  2003cited by this paper
• Lokal ablative Therapien des hepatozellulären Karzinoms

  2001cited by this paper
• [Locally ablative therapies of hepatocellular carcinoma].

  2001cited by this paper
• Angiogenesis Research: Guidelines for Translation to Clinical Application

  2001cited by this paper
• Adjuvant treatment for colorectal cancer.

  2001cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• [New guidelines to evaluate the response to treatment in solid tumors].

  2000cited by this paper
• p53 and lung cancer.

  1997cited by this paper
• Adjuvant treatment for colorectal cancer

  1996cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper

• Robotic-assisted and electromagnetic navigation bronchoscopy for multi-focal lung cancers: a narrative review

  2025cites this paper
• Lung Cryoablation: Patient Selection, Techniques, and Postablation Imaging.

  2025cites this paper
• Investigation of Lung Cancer Cell Response to Cryoablation and Adjunctive Gemcitabine-Based Cryo-Chemotherapy Using the A549 Cell Line

  2024cites this paper
• Cutting-Edge Therapies for Lung Cancer

  2024cites this paper
• Cryoablation and immunity in non-small cell lung cancer: a new era of cryo-immunotherapy

  2023cites this paper
• Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation

  2022cites this paper
• Image-guided percutaneous ablation for lung malignancies

  2022cites this paper
• Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis

  2022cites this paper
• Construction of a prognostic risk assessment model for lung adenocarcinoma based on Integrin β family‐related genes

  2022cites this paper
• In Vitro Investigation of Renal Cell Carcinoma Response to Combination Sorafenib and Cryoablation Treatment

  2022cites this paper
• Ablation Therapy Combined with EGFR TKIs in the Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

  2021cites this paper
• Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art

  2021cites this paper
• Current Management of Oligometastatic Lung Cancer and Future Perspectives: Results of Thermal Ablation as a Local Ablative Therapy

  2021cites this paper
• Percutaneous lung tumour ablation

  2020cites this paper
• Percutaneous image-guided ablation: From techniques to treatments.

  2019cites this paper
• Cryoablation and immunotherapy: an overview of evidence on its synergy

  2019cites this paper
• Primary tumors of the lung: should we consider thermal ablation as a valid therapeutic option?

  2019cites this paper
• Defeating Cancers’ Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer’s Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome

  2018cites this paper
• Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive Review.

  2018cites this paper
• Models and Mechanisms of Tissue Injury in Cryosurgery

  2018cites this paper
• Cryotherapy: Application in the Airways

  2018cites this paper
• The Story of Adjuvants to Boost the Performance of Cryoablation

  2017cites this paper
• Percutaneous thermal ablation of lung tumors - Radiofrequency, microwave and cryotherapy: Where are we going?

  2017cites this paper
• Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit?

  2016cites this paper
• Enhanced Cryoablative Methodologies

  2016cites this paper
• Combined therapy of percutaneous cryoablation and traditional Chinese medicine can be a promising strategy for elderly or advanced lung cancer patients based on a retrospective clinical study.

  2014cites this paper